Kaiser Permanente's highly successful integrated healthcare delivery model has been a tough act for other healthcare systems to follow, and new research suggests their nurses might be the key.
Kaiser Permanente's highly successful integrated healthcare delivery model has been a tough act for other healthcare systems to follow. Now, new research from the University of Pennsylvania suggests that Kaiser's focus on nurses as an important part of care delivery might be the key.
In their study published online in Health Care Management Review, the authors evaluated data from 2006 to 2007 for 564 acute-care hospitals in 4 states to examine whether patient (mortality and failure-to-rescue) and nurse (burnout, job satisfaction, and intent-to-leave) outcomes in Kaiser hospitals were better than in non-Kaiser hospitals, and whether the differences in nursing could help explain patient clinical outcomes. They also compared Kaiser outcomes with Magnet hospitals known to have better nursing work environments.
The authors conclude that differences in nursing explained a significant proportion of the Kaiser outcomes advantage.
Read the associated press release at newswise
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Functional Similarity Between Ustekinumab Biosimilar ABP 654, Stelara in Crohn Disease
March 10th 2025Functional similarity of the ustekinumab biosimilar ABP 654 (Wezlana) and the reference product (Stelara) was confirmed by a series of in vitro studies, which support the totality of evidence for the biosimilar's FDA approval.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen